title: Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins.
abstract: Schizophrenia unfolds during the late period of brain maturation, while myelination is still continuing. In the present study, we used MRI and T2 relaxation analysis to measure the myelin water fraction in schizophrenia. In schizophrenia (n=30) compared with healthy subjects (n=27), overall white matter showed 12% lower myelin water fraction (P=0.031), with the most prominent effects on the left genu of the corpus callosum (36% lower, P=0.002). The left anterior genu was affected in both first-episode (P=0.035) and chronic patients (P=0.011). In healthy subjects, myelin water fraction in total white matter and in frontal white matter increased with age, and with years of education, indicating ongoing maturation. In patients with schizophrenia, neither relation was statistically significant. Post-mortem studies of anterior frontal cortex demonstrated less immunoreactivity of two oligodendrocyte-associated proteins in schizophrenia (2',3'-cyclic nucleotide 3'-phosphodiesterase by 33%, P=0.05; myelin-associated glycoprotein by 27%, P=0.14). Impaired myelination in schizophrenia could contribute to abnormalities of neural connectivity and persistent functional impairment in the illness.
authors.affiliation: Centre for Complex Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
authors.forename: S W
authors.initials: SW
authors.lastname: Flynn
authors.forename: D J
authors.initials: DJ
authors.lastname: Lang
authors.forename: A L
authors.initials: AL
authors.lastname: Mackay
authors.forename: V
authors.initials: V
authors.lastname: Goghari
authors.forename: I M
authors.initials: IM
authors.lastname: Vavasour
authors.forename: K P
authors.initials: KP
authors.lastname: Whittall
authors.forename: G N
authors.initials: GN
authors.lastname: Smith
authors.forename: V
authors.initials: V
authors.lastname: Arango
authors.forename: J J
authors.initials: JJ
authors.lastname: Mann
authors.forename: A J
authors.initials: AJ
authors.lastname: Dwork
authors.forename: P
authors.initials: P
authors.lastname: Falkai
authors.forename: W G
authors.initials: WG
authors.lastname: Honer
mesh_terms: D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000032:analysis; D000328:Adult; D001823:Body Composition / Q000502:physiology; D001825:Body Fluid Compartments / Q000502:physiology; D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D016555:Matched-Pair Analysis; D008875:Middle Aged; D009186:Myelin Sheath / Q000737:chemistry; D018992:Myelin-Associated Glycoprotein / Q000032:analysis; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D009836:Oligodendroglia / Q000737:chemistry / Q000473:pathology; D012016:Reference Values; D012559:Schizophrenia / Q000150:complications / Q000473:pathology*; D014867:Water / Q000032:analysis
chemical_list: D018992:Myelin-Associated Glycoprotein; D014867:Water; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases